Preparation method for novel adjuvant piglet Escherichia coli inactivated vaccine

A technology of Escherichia coli and inactivated vaccine, which is applied to medical preparations containing active ingredients, antibacterial drugs, pharmaceutical formulations, etc., can solve the problems of large residual amount, poor immune effect, and unfavorable use of meaty poultry, etc. Avoid immune tolerance, eliminate application, reduce the effect of animal disturbance

Inactive Publication Date: 2016-04-06
王保宁
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Vaccine prevention and control adopts the suspension liquid vaccine made by adding aluminum hydroxide after bacterial culture and inactivation. The aluminum hydroxide added to this immune vaccine has a large residual amount after use, which is not conducive to the use of meat poultry, and the existing vaccine has immunity Ineffective problem, need to provide a vaccine to enhance the immune effect to prevent diarrhea in piglets

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method for novel adjuvant piglet Escherichia coli inactivated vaccine
  • Preparation method for novel adjuvant piglet Escherichia coli inactivated vaccine
  • Preparation method for novel adjuvant piglet Escherichia coli inactivated vaccine

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0028] Example 1

[0029] Escherichia coli strains: isolated, identified, screened and conserved by the research team of the Highland Animal Disease Detection Center, College of Animal Science, College of Agriculture and Animal Husbandry, Tibet University.

[0030] Mannitol 2013103101, Chengdu Kelong Chemical; LB medium: Tryptone10g, YeastExtract5g, NaCl10g, with ddH 2 Dilute the volume to 1000ml with O, adjust the pH to 7.0, sterilize by autoclaving, and store at 4°C.

[0031] LB medium plate: Tryptone 10g, YeastExtract 5g, NaCl 10g, agar 20g, fixed to ddH 2 O1000ml, adjust pH to 7.0, autoclave for 20min, pour the dissolved LB medium into a sterilized plate under an alcohol lamp, cool and solidify and store at 4°C for later use.

[0032] Kanamycin (stock solution): Kanamycin 0.3g, dilute to ddH 2 O10ml, filter and sterilize with 0.22um filter, and store at -20℃ for later use.

[0033] Chloramphenicol (storage solution): 0.34g of chloramphenicol, dilute to 10ml of absolute et

Example Embodiment

[0074] Example 2

[0075] Immunization method:

[0076] The piglets were orally immunized with Escherichia coli inactivated adjuvant vaccine according to the immunization schedule of 0, 14, 28, and 42 days for a total of 4 times. Before each immunization, the vaccine was reconstituted with distilled water and injected intramuscularly: 4ul-40ul per gram of animal body weight The amount of bacteria is 10 6 -10 10 CFU / ml vaccine; oral 1ml-10ml bacteria per kg animal body weight is 10 6 -10 10 CFU / ml vaccine, stirred until the temperature is lower than room temperature and fed to the animals to be immunized.

Example Embodiment

[0077] Example 3

[0078] (1) Detection of immune effect

[0079] Immunization: Mice were immunized with adjuvanted and unadjuvanted vaccines respectively, and the immunization schedule was performed on 0, 14, 28, and 42 days. Intramuscular injection or oral immunization was used for a total of 4 times. The vaccine was reconstituted with distilled water before each immunization. Immunization by intramuscular injection: 4ul-40ul per gram of animal body weight, and the bacterial volume was 10 6 -10 10 CFU / ml vaccine; Oral immunization: 1-10ml bacterial volume is 10 6 -10 10 The vaccine at CFU / ml was stirred until the temperature was lower than room temperature and fed to the animals to be immunized.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Concentrationaaaaaaaaaa
Login to view more

Abstract

The invention discloses a preparation method for a novel adjuvant piglet Escherichia coli inactivated vaccine. The preparation method includes the steps that (1) bacterial strains are subjected to separation and extraction, and bacterium liquid antigens are prepared; (2) a vaccine stock solution is prepared; (3) in preparation of the vaccine finished product, mannose or mannitol which accounts for 3-5% of the mass of the vaccine stock solution is added into the vaccine stock solution, and the mixture is freeze-dried after being subpackaged. Through adding vaccine biological adjuvant recombined CTB into the vaccine bacterium liquid and effectively controlling the adding amount, the inactivated vaccine is obtained; the inactivated vaccine can effectively increase the quantity of intestinal juice specific IgG/IgA antibodies through four times of immunization, the purpose of effectively enhancing intestinal tract and blood immunity is achieved, the 100% protection effect on Escherichia coli attack can be achieved through intramuscular injection and oral taking of different doses of vaccines, and the novel vaccine and the novel immunization method are provided for pathogenic Escherichia coli.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner 王保宁
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products